Lomefloxacin interactions
Full monograph for LomefloxacinCheck it against another medicine
Medicines
394 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Acyclovir + Hydrocortisone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Amiodarone Hydrochloride | Major | Synergy | Quinolones such as ciprofloxacin, gatifloxacin, gemifloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin, ofloxacin, and sparfloxacin may cause… | 41 sources — open the full entry |
| Amisulpride | Major | Synergy | Amisulpride can cause dose- and concentration-dependent prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the… | 3 sources — open the full entry |
| Arsenic Trioxide | Major | Synergy | Arsenic trioxide can cause QT interval prolongation and complete atrioventricular block. Theoretically, coadministration with other agents that can prolong the… | 4 sources — open the full entry |
| Artemether + Lumefantrine | Major | Synergy | Artemether-lumefantrine may cause prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval may…2 documented mechanisms | 16 sources — open the full entry |
| Bempedoic acid | Major | Synergy | Concomitant administration of bempedoic acid may potentiate the risk of tendon rupture or injury associated with fluoroquinolones and corticosteroids. The… | 2 sources — open the full entry |
| Bempedoic acid + Ezetimibe | Major | Synergy | Concomitant administration of bempedoic acid may potentiate the risk of tendon rupture or injury associated with fluoroquinolones and corticosteroids. The… | 2 sources — open the full entry |
| Betamethasone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone + Calcipotriol | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone + Clotrimazole | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone + Clotrimazole + Gentamicin | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone + Neomycin Sulphate (Ophthalmic) | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone + Phenylephrine + Lignocaine | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone Dipropionate | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone Dipropionate + Salicylic Acid | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism…2 documented mechanisms | 21 sources — open the full entry |
| Betamethasone Sodium Phosphate | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Betamethasone Valerate | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Biphasic Insulin Aspart | Major | Others | Quinolone antibiotics may interfere with the therapeutic effects of insulin and other antidiabetic agents. The use of quinolones has been associated with… | 40 sources — open the full entry |
| Bupropion Hydrochloride | Major | Synergy | The use of bupropion is associated with a dose-related risk of seizures. The risk may be further increased when coadministered with selective serotonin… | 19 sources — open the full entry |
| Cabozantinib | Major | Synergy | Cabozantinib can cause prolongation of the QT interval. | 7 sources — open the full entry |
| Calcium Dobesilate + Lidocaine + Dexamethasone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Ceritinib | Major | Synergy | Ceritinib can cause concentration-dependent prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval… | 9 sources — open the full entry |
| Chloroquine Phosphate | Major | Synergy | Chloroquine and hydroxychloroquine can cause dose-related prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong… | 22 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Framycetin + Esculin | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Neomycin + Esculin | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Ciprofloxacin + Dexamethasone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism…2 documented mechanisms | 31 sources — open the full entry |
| Citalopram Hydrobromide | Major | Synergy | Citalopram can cause dose-dependent prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval may… | 15 sources — open the full entry |
| Clotrimazole + Hydrocortisone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Clozapine | Major | Synergy | Clozapine has the potential to prolong QT interval of the electrocardiogram. Theoretically, coadministration with other agents that can cause QT prolongation… | 13 sources — open the full entry |
| Crizotinib | Major | Synergy | Crizotinib can cause concentration-dependent prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT… | 6 sources — open the full entry |
| Deflazacort | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dexamethasone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dexamethasone + Chloramphenicol | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dexamethasone + Levofloxacin | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dexamethasone + Neomycin + Glacial Acetic Acid | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dexamethasone + Neomycin Sulphate + Polymyxin B Sulphate | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dexamethasone + Tobramycin | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Dextromethorphan + Bupropion | Major | Synergy | The use of bupropion is associated with a dose-related risk of seizures. The risk may be further increased when coadministered with selective serotonin… | 19 sources — open the full entry |
| Econazole Nitrate + Triamcinolone Acetonide | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Efavirenz | Major | Metabolism | Efavirenz can cause significant QT interval prolongation in patients with the CYP450 2B6 *6/*6 genotype due to reduced metabolic clearance of the drug stemming… | 6 sources — open the full entry |
| Escitalopram Oxalate | Major | Synergy | Escitalopram can cause dose-dependent prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval may… | 13 sources — open the full entry |
| Fludrocortisone Acetate | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Fusidic acid + Betamethasone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Fusidic acid + Hydrocortisone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Gatifloxacin + Dexamethasone | Major | Synergy | Concomitant administration of corticosteroids may potentiate the risk of tendinitis and tendon rupture associated with fluoroquinolone treatment. The mechanism… | 7 sources — open the full entry |
| Glibenclamide | Major | Antagonism | Quinolone antibiotics may interfere with the therapeutic effects of insulin and other antidiabetic agents. The use of quinolones has been associated with… | 50 sources — open the full entry |
| Glimepiride | Major | Antagonism | Quinolone antibiotics may interfere with the therapeutic effects of insulin and other antidiabetic agents. The use of quinolones has been associated with… | 50 sources — open the full entry |
| Glimepiride + Metformin | Major | Antagonism | Quinolone antibiotics may interfere with the therapeutic effects of insulin and other antidiabetic agents. The use of quinolones has been associated with…2 documented mechanisms | 100 sources — open the full entry |
| Glipizide | Major | Antagonism | Quinolone antibiotics may interfere with the therapeutic effects of insulin and other antidiabetic agents. The use of quinolones has been associated with… | 50 sources — open the full entry |
| Glipizide + Metformin Hydrochloride | Major | Antagonism | Quinolone antibiotics may interfere with the therapeutic effects of insulin and other antidiabetic agents. The use of quinolones has been associated with…2 documented mechanisms | 100 sources — open the full entry |
This source documents no food, condition or duplication entries for Lomefloxacin.